Applied health economics

Course director: András Inotai

4-day course in health policy (2 credits)

Each day consists of 6 x 45-minute classes

Day 1	Principles of health economics, elements of health technology assessment, economic evaluations	Zoltán Kaló/ András Inotai
Day 2	Development of cost-effectiveness and budget impact models to support pharmaceutical policy decisions	Balázs Nagy
Day 3	Theory and practice of managed entry decisions	András Inotai
Day 4	Principles and implementation of value frameworks and Multicriteria Decision Analyses to support policy decisions	Zoltán Kaló

Technical requirements: participants should bring their own computer

Evaluation of prior PhD courses by participants and Action plan (in HU):

EVIDENCE-BASED PHARMACEUTICAL POLICY DECISION-MAKING IN LOWER-INCOME EUROPEAN COUNTRIES Evaluation

2024/25/II:

Evaluation of PhD courses by participants and Action plan (in HU)::

Hallgatói visszajelzés és akcióterv_04_09

A kurzus előreláthatólag 2027 tavaszán indul ismét. Pontosabb információ 2026. második felében várható.

Archív:

HEALTH ECONOMICS COURSE

organised by the

Center for Health Technology Assessment,

SEMMELWEIS UNIVERSITY, Budapest

COURSE DATE: 17-20 February 2025, 9 AM-4 PM

Applied health economics: Evidence-based pharmaceutical policy decision-making in lower-income European countries

For Whom?

For representatives of health care payers, HTA agencies, academic research teams and market access teams of the pharmaceutical industry or consultant companies who are involved or interested in-, or influenced by evidence-based policy decisions in countries with economic constraints.

Why?

Evidence-based decision-making is especially important in less affluent countries with more limited health care resources and generally poorer overall health status, as the opportunity cost of suboptimal pharmaceutical policy decisions is higher in these countries.

Brief description

The course – in parallel with providing basic insights into the theory of economic evaluation, modeling, managed entry agreements and multi criteria decision analysis (MCDA) – will primarily be based on case studies. Participants will develop an economic model and use it for designing managed entry agreement scenarios and understanding their influence on the cost-effectiveness and the budget impact of pharmaceuticals at their market entry. As the traditional economic value frameworks may be too narrow to capture patient-centric and societal value elements, participants will develop an extended value framework and evaluate policy scenarios by MCDA.

Participation will be face-to-face (seating is limited).

Lecturers:

Prof. Zoltán Kaló Assoc. Prof. András Inotai

For more information, please download our detailed brochures from here:

Applied_Health_Economics_Flyer_Q1_2025

Registration

Please note: participation is free of charge for faculty members and students of Semmelweis University.

In order to register for our winter courses:

download our application form: (available from November 2026)
fill out the form,
send the completed form in a .pdf format to hta@semmelweis.hu via email.

Important: After sending your registration form by email, please wait for receiving your invoice first. Only after you received your invoice transfer the registration fee.

Thank you!